These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21041786)

  • 1. Change in plasma Aß peptides and onset of dementia in adults with Down syndrome.
    Schupf N; Zigman WB; Tang MX; Pang D; Mayeux R; Mehta P; Silverman W
    Neurology; 2010 Nov; 75(18):1639-44. PubMed ID: 21041786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
    Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
    J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease.
    Startin CM; Ashton NJ; Hamburg S; Hithersay R; Wiseman FK; Mok KY; Hardy J; Lleó A; Lovestone S; Parnetti L; Zetterberg H; Hye A; ; Strydom A
    Alzheimers Res Ther; 2019 Mar; 11(1):26. PubMed ID: 30902060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.
    Mehta PD; Pirttilä T; Mehta SP; Sersen EA; Aisen PS; Wisniewski HM
    Arch Neurol; 2000 Jan; 57(1):100-5. PubMed ID: 10634455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer's disease.
    Shahpasand-Kroner H; Klafki HW; Bauer C; Schuchhardt J; Hüttenrauch M; Stazi M; Bouter C; Wirths O; Vogelgsang J; Wiltfang J
    Alzheimers Res Ther; 2018 Dec; 10(1):121. PubMed ID: 30526652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased amyloid beta protein levels in children and adolescents with Down syndrome.
    Mehta PD; Capone G; Jewell A; Freedland RL
    J Neurol Sci; 2007 Mar; 254(1-2):22-7. PubMed ID: 17275850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
    Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
    Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum NGAL is Associated with Distinct Plasma Amyloid-β Peptides According to the Clinical Diagnosis of Dementia in Down Syndrome.
    Naudé PJ; Dekker AD; Coppus AM; Vermeiren Y; Eisel UL; van Duijn CM; Van Dam D; De Deyn PP
    J Alzheimers Dis; 2015; 45(3):733-43. PubMed ID: 25613101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study.
    Seppälä TT; Herukka SK; Hänninen T; Tervo S; Hallikainen M; Soininen H; Pirttilä T
    J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1123-7. PubMed ID: 20478847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of Rabbit Monoclonal Antibody to Amyloid-β38 (Aβ38): Increased Plasma Aβ38 Levels in Down Syndrome.
    Mehta PD; Patrick BA; Barshatzky M; Mehta SP; Frackowiak J; Mazur-Kolecka B; Miller DL
    J Alzheimers Dis; 2015; 46(4):1021-32. PubMed ID: 26402629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma amyloid-β as a function of age, level of intellectual disability, and presence of dementia in Down syndrome.
    Head E; Doran E; Nistor M; Hill M; Schmitt FA; Haier RJ; Lott IT
    J Alzheimers Dis; 2011; 23(3):399-409. PubMed ID: 21116050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated plasma beta-amyloid peptide Abeta(42) levels, incident dementia, and mortality in Down syndrome.
    Schupf N; Patel B; Pang D; Zigman WB; Silverman W; Mehta PD; Mayeux R
    Arch Neurol; 2007 Jul; 64(7):1007-13. PubMed ID: 17620492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of the Plasma Aβ40/Aβ42 Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease.
    Kim HJ; Park KW; Kim TE; Im JY; Shin HS; Kim S; Lee DH; Ye BS; Kim JH; Kim EJ; Park KH; Han HJ; Jeong JH; Choi SH; Park SA
    J Alzheimers Dis; 2015; 48(4):1043-50. PubMed ID: 26444752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease.
    Chatterjee P; Elmi M; Goozee K; Shah T; Sohrabi HR; Dias CB; Pedrini S; Shen K; Asih PR; Dave P; Taddei K; Vanderstichele H; Zetterberg H; Blennow K; Martins RN
    J Alzheimers Dis; 2019; 71(3):775-783. PubMed ID: 31424403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression and plasma amyloid beta peptides in the elderly with and without the apolipoprotein E4 allele.
    Sun X; Chiu CC; Liebson E; Crivello NA; Wang L; Claunch J; Folstein M; Rosenberg I; Mwamburi DM; Peter I; Qiu WQ
    Alzheimer Dis Assoc Disord; 2009; 23(3):238-44. PubMed ID: 19812466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment.
    Blennow K; De Meyer G; Hansson O; Minthon L; Wallin A; Zetterberg H; Lewczuk P; Vanderstichele H; Vanmechelen E; Kornhuber J; Wiltfang J; ; Heuser I; Maier W; Luckhaus C; Rüther E; Hüll M; Jahn H; Gertz HJ; Frölich L; Hampel H; Pernetzki R
    J Nutr Health Aging; 2009 Mar; 13(3):205-8. PubMed ID: 19262954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma beta amyloid level and depression in older adults.
    Metti AL; Cauley JA; Newman AB; Ayonayon HN; Barry LC; Kuller LM; Satterfield S; Simonsick EM; Yaffe K
    J Gerontol A Biol Sci Med Sci; 2013 Jan; 68(1):74-9. PubMed ID: 22499763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics.
    Rippon B; Palta P; Tahmi M; Sherwood G; Soto L; Cespedes S; Mesen Y; He H; Laing K; Moreno H; Teresi J; Razlighi Q; Brickman AM; Zetterberg H; Luchsinger JA
    J Alzheimers Dis; 2022; 87(3):1229-1238. PubMed ID: 35466933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Composite Scores of Plasma Tau and β-Amyloids Correlate with Dementia in Down Syndrome.
    Fang WQ; Hwu WL; Chien YH; Yang SY; Chieh JJ; Chang LM; Huang AC; Lee NC; Chiu MJ
    ACS Chem Neurosci; 2020 Jan; 11(2):191-196. PubMed ID: 31799825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher Plasma Amyloid-β Levels Are Associated with a Higher Risk of Cancer: A Population-Based Prospective Cohort Study.
    van der Willik KD; Ghanbari M; Fani L; Compter A; Ruiter R; Stricker BHC; Schagen SB; Ikram MA
    Cancer Epidemiol Biomarkers Prev; 2020 Oct; 29(10):1993-2001. PubMed ID: 32727725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.